Cargando…

Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats

PURPOSE: Studies to explore angiotensin II (Ang II) and its downstream signaling pathways via Rho guanine nucleotide exchange factors (RhoGEFs) and RhoA signaling are crucial to understanding the mechanisms of smooth muscle contraction leading to hypertension. This study aimed to investigate the Ang...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Wei-Chiao, Juang, Jyh-ming, Chang, Shen-nan, Wu, Cho-kai, Tsai, Chia-ti, Tseng, Chuen-den, Tseng, Yung-zu, Su, Ming-Jai, Chiang, Fu-tien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518287/
https://www.ncbi.nlm.nih.gov/pubmed/23233801
http://dx.doi.org/10.2147/IJN.S36700
_version_ 1782252551753695232
author Chiu, Wei-Chiao
Juang, Jyh-ming
Chang, Shen-nan
Wu, Cho-kai
Tsai, Chia-ti
Tseng, Chuen-den
Tseng, Yung-zu
Su, Ming-Jai
Chiang, Fu-tien
author_facet Chiu, Wei-Chiao
Juang, Jyh-ming
Chang, Shen-nan
Wu, Cho-kai
Tsai, Chia-ti
Tseng, Chuen-den
Tseng, Yung-zu
Su, Ming-Jai
Chiang, Fu-tien
author_sort Chiu, Wei-Chiao
collection PubMed
description PURPOSE: Studies to explore angiotensin II (Ang II) and its downstream signaling pathways via Rho guanine nucleotide exchange factors (RhoGEFs) and RhoA signaling are crucial to understanding the mechanisms of smooth muscle contraction leading to hypertension. This study aimed to investigate the Ang II–induced expression of RhoGEFs in vascular smooth muscle cells (VSMCs) of spontaneously hypertensive rats (SHRs) and to identify the possible regulator associated with hypertension. METHODS: Cultured VSMCs of the aorta from SHRs and Wistar-Kyoto (WKY) rats were treated with or without Ang II or Ang II plus Ang II type 2 receptor antagonists. The expression levels of RhoGEF messenger RNA (mRNA) and protein were determined. To evaluate the changes of aortic ring contractile force in response to Ang II, a nonviral carrier system was adopted to deliver the leukemia-associated RhoGEF (LARG) small interfering RNA via nanoparticles into aortic rings. RESULTS: The baseline mRNA levels of three RhoGEFs in cultured VSMCs of WKY rats did not increase with age, but they were significantly higher in 12-week-old SHRs than in 5-week-old SHRs. Expression levels of LARG mRNA were higher in SHRs than in age-matched WKY rats. The baseline LAGR protein of 12-week-old SHRs was about four times higher than that of WKY rats of the same age. After Ang II–stimulation, LAGR protein expression was significantly increased in 12-week-old WKY rats but remained unchanged in 12-week-old SHRs. LARG small interfering RNA was successfully delivered into aortic rings using nanoparticles. LARG knockdown resulted in 12-week-old SHRs showing the greatest reduction in aortic ring contraction. CONCLUSION: There were differences in age-related RhoGEF expression at baseline and in response to Ang II–stimulation between SHRs and WKY rats in this study. Nanotechnology can assist in studying the silencing of LARG in tissue culture. The findings of this study indicate that LARG gene expression may be associated with the genesis of hypertension in SHRs.
format Online
Article
Text
id pubmed-3518287
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-35182872012-12-11 Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats Chiu, Wei-Chiao Juang, Jyh-ming Chang, Shen-nan Wu, Cho-kai Tsai, Chia-ti Tseng, Chuen-den Tseng, Yung-zu Su, Ming-Jai Chiang, Fu-tien Int J Nanomedicine Original Research PURPOSE: Studies to explore angiotensin II (Ang II) and its downstream signaling pathways via Rho guanine nucleotide exchange factors (RhoGEFs) and RhoA signaling are crucial to understanding the mechanisms of smooth muscle contraction leading to hypertension. This study aimed to investigate the Ang II–induced expression of RhoGEFs in vascular smooth muscle cells (VSMCs) of spontaneously hypertensive rats (SHRs) and to identify the possible regulator associated with hypertension. METHODS: Cultured VSMCs of the aorta from SHRs and Wistar-Kyoto (WKY) rats were treated with or without Ang II or Ang II plus Ang II type 2 receptor antagonists. The expression levels of RhoGEF messenger RNA (mRNA) and protein were determined. To evaluate the changes of aortic ring contractile force in response to Ang II, a nonviral carrier system was adopted to deliver the leukemia-associated RhoGEF (LARG) small interfering RNA via nanoparticles into aortic rings. RESULTS: The baseline mRNA levels of three RhoGEFs in cultured VSMCs of WKY rats did not increase with age, but they were significantly higher in 12-week-old SHRs than in 5-week-old SHRs. Expression levels of LARG mRNA were higher in SHRs than in age-matched WKY rats. The baseline LAGR protein of 12-week-old SHRs was about four times higher than that of WKY rats of the same age. After Ang II–stimulation, LAGR protein expression was significantly increased in 12-week-old WKY rats but remained unchanged in 12-week-old SHRs. LARG small interfering RNA was successfully delivered into aortic rings using nanoparticles. LARG knockdown resulted in 12-week-old SHRs showing the greatest reduction in aortic ring contraction. CONCLUSION: There were differences in age-related RhoGEF expression at baseline and in response to Ang II–stimulation between SHRs and WKY rats in this study. Nanotechnology can assist in studying the silencing of LARG in tissue culture. The findings of this study indicate that LARG gene expression may be associated with the genesis of hypertension in SHRs. Dove Medical Press 2012 2012-12-04 /pmc/articles/PMC3518287/ /pubmed/23233801 http://dx.doi.org/10.2147/IJN.S36700 Text en © 2012 Chiu et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Chiu, Wei-Chiao
Juang, Jyh-ming
Chang, Shen-nan
Wu, Cho-kai
Tsai, Chia-ti
Tseng, Chuen-den
Tseng, Yung-zu
Su, Ming-Jai
Chiang, Fu-tien
Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats
title Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats
title_full Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats
title_fullStr Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats
title_full_unstemmed Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats
title_short Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats
title_sort differential baseline expression and angiotensin ii–stimulation of leukemia-associated rhogef in vascular smooth muscle cells of spontaneously hypertensive rats
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518287/
https://www.ncbi.nlm.nih.gov/pubmed/23233801
http://dx.doi.org/10.2147/IJN.S36700
work_keys_str_mv AT chiuweichiao differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats
AT juangjyhming differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats
AT changshennan differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats
AT wuchokai differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats
AT tsaichiati differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats
AT tsengchuenden differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats
AT tsengyungzu differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats
AT sumingjai differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats
AT chiangfutien differentialbaselineexpressionandangiotensiniistimulationofleukemiaassociatedrhogefinvascularsmoothmusclecellsofspontaneouslyhypertensiverats